SAN DIEGO (AP) _ Retrophin Inc. (RTRX) on Tuesday reported a loss of $41 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 99 cents. Losses, adjusted for non-recurring costs and stock option expense, came to 63 cents per share.
The drug developer posted revenue of $39.6 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $42 million.
Retrophin shares have dropped 17% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $18.86, a drop of 21% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RTRX at https://www.zacks.com/ap/RTRX